Year in Review: Ovarian Cancer: PARP inhibitors, genetic testing, and novel combinations External Web Site Icon I Ingram, Medpage Today, November 1, 2019

Hot Topics of the Day|PHGKB

What's New

Last Posted: Nov 03, 2019

---

• Year in Review: Ovarian Cancer: PARP inhibitors, genetic testing, and novel combinations 
  I Ingram, Medpage Today, November 1, 2019
• The BRCA gene is about so much more than breast cancer risk 
  A Goldman, Well and Good, October 27, 2019
• PARP Inhibitors Show Promise as Initial Treatment for Ovarian Cancer 
  NCI, October 29, 2019
• A comprehensive understanding of ovarian carcinoma survival prognosis by novel biomarkers. 
  Wang Y et al. European review for medical and pharmacological sciences 2019 Oct 23(19) 8257-8264
• Alaska Native Patient and Provider Perspectives on the Multitarget Stool DNA Test Compared With Colonoscopy for Colorectal Cancer Screening. 
  Redwood Diana G et al. Journal of primary care & community health 102150132719884295
• Assessment of Diagnostic Outcomes of RNA Genetic Testing for Hereditary Cancer. 
  Karam Rachid et al. JAMA network open 2019 Oct 2(10) e1913900
• Breast cancer risk assessment in patients who test negative for a hereditary cancer syndrome. 
  Breit Caroline et al. American journal of surgery 2019 Oct
• Circulating tumor cell free DNA from plasma and urine in the clinical management of colorectal cancer. 
  Yu Haiying et al. Cancer biomarkers : section A of Disease markers 2019 Oct
• Cost-comparison analysis of a multiplatform tumour profiling service to guide advanced cancer treatment. 
  Spizzo Gilbert et al. Cost effectiveness and resource allocation : C/E 2019 1723
• Cost-Effectiveness Analysis of Upfront SBRT for Oligometastatic Stage IV Non-Small Cell Lung Cancer Based on Mutational Status. 
  Kim Hayeon et al. American journal of clinical oncology 2019 Nov 42(11) 837-844
• Does preventive oophorectomy increase the risk of depression in BRCA mutation carriers? 
  Kotsopoulos Joanne et al. Menopause (New York, N.Y.) 2019 Oct
• Family Health Leaders: Lessons on Living with Li-Fraumeni Syndrome across Generations. 
  Pantaleao Ashley et al. Family process 2019 Oct
• Identification of a New Eight-Long Noncoding RNA Molecular Signature for Breast Cancer Survival Prediction. 
  Zhang Yaqiong et al. DNA and cell biology 2019 Oct
• Investigation on the hereditary basis of colorectal cancers in an African population with frequent early onset cases. 
  Katsidzira Leolin et al. PloS one 2019 14(10) e0224023
• Mainstreaming of genomic medicine in gastroenterology, present and future: a nationwide survey of UK gastroenterology trainees. 
  Al Bakir Ibrahim et al. BMJ open 2019 Oct 9(10) e030505